Finance

Lists
Why is AMBU-B up 3.50%?
Dive Deeper
AMBU-B:CPH
Ambu A/S
DKK 90.30
+3.50%
(+3.05) 1D
Nov 13, 3:26:41 PM GMT+1  ·   DKK
All symbols
SymbolPriceChange% Change
Generating top insights for AMBU-B...
Open
DKK 87.90
High
DKK 90.65
Low
DKK 87.40
Mkt. cap
20.50B
Avg. vol.
759.91K
Volume
525.77K
52-wk high
DKK 93.25
52-wk low
DKK 56.25
Shares outstanding
234.97M
No. of employees
5K
Open
DKK 87.90
High
DKK 90.65
Low
DKK 87.40
Mkt. cap
20.50B
Avg. vol.
759.91K
Volume
525.77K
52-wk high
DKK 93.25
52-wk low
DKK 56.25
Shares outstanding
234.97M
No. of employees
5K
News stories
From web sources and news partners
Profile
Ambu, or officially Ambu A/S, is a Danish company that develops, produces and markets single-use endoscopy solutions, diagnostic and life-supporting equipment to hospitals, private practices, and rescue services. It was founded in Denmark in 1937, as Testa Laboratorium, by German engineer Holger Hesse. The largest business areas are anesthesia, cardiology, neurology, pulmonology, urology and gastroenterology. The company's most important products are devices for artificial ventilation, single-use endoscopes and single-use electrodes for ECG tests and neurophysiological mappings. Wikipedia
About Ambu A/S
CEOBritt Meelby Jensen
Employees4.66K
Founded1937
Headquarters-
SectorHealth Care
IndustryMedical device
Websiteambu.com
Previous reportsAll values in DKK
Loading Previous Earnings...
Revenue
Net income
All values in DKK
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.56B
1.57B
1.64B
1.70B
Cost of goods sold
611.00M
625.00M
665.00M
680.00M
Cost of revenue
611.00M
625.00M
665.00M
680.00M
Research and development expenses
94.00M
91.00M
87.00M
97.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
689.00M
684.00M
667.00M
630.00M
Operating expense
783.00M
775.00M
754.00M
727.00M
Total operating expenses
1.39B
1.40B
1.42B
1.41B
Operating income
164.00M
173.00M
221.00M
293.00M
Other non operating income
-
-
-
-
EBT including unusual items
153.00M
157.00M
203.00M
327.00M
EBT excluding unusual items
153.00M
157.00M
203.00M
327.00M
Income tax expense
35.00M
36.00M
47.00M
80.00M
Effective tax rate
22.88%
22.93%
23.15%
24.46%
Other operating expenses
-
-
-
-
Net income
118.00M
121.00M
156.00M
247.00M
Net profit margin
7.57%
7.69%
9.51%
14.53%
Earnings per share
0.44
0.46
0.59
0.93
Interest and investment income
4.00M
3.00M
6.00M
42.00M
Interest expense
-15.00M
-19.00M
-24.00M
-
Net interest expenses
-11.00M
-16.00M
-18.00M
42.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
261.00M
271.00M
321.00M
323.25M
Gain or loss from assets sale
-
-
-
10.00M
Upcoming events
AI content may include mistakes. Learn more
Google apps